LINC has a working machine now. The harder test starts with its 50-person pilot

When I first wrote about LINC, it was concept renders and a bold promise: a countertop machine that reads your wearable and pours a personalised supplement drink, morning and evening. I liked the ambition and said the hard part was still ahead. After that piece ran, I reached out to the founder, Paul O'Connor, and we got into a proper conversation about where LINC is headed. He shared the company's latest materials, so here we are at the next step. For transparency: I approached LINC, we spoke directly, and the company provided the press kit and the prototype images used here. This is an opinion piece, nothing about it is paid, and the critical take is my own.

LINC is no longer a render

The biggest change is that LINC is no longer a concept. The company has shown a working prototype that it says brings the fluidics, pumps, electronics and interface together in one device, and reports that its own testing has confirmed accurate, repeatable dosing. It is now preparing a 50-person pilot that will put the machine into real homes for the first time, ahead of a commercial launch the company now places in Austin, Texas, in 2027. Earlier materials pointed to Dubai, so the launch geography seems to have shifted.

A marketer's eye, and why that cuts both ways

It helps to know who is building this. O'Connor spent two decades in global brand marketing at adidas, Unilever and L'Oreal, and was part of the adidas Liquid Billboard work that won a Cannes Lions Grand Prix in 2022. That pedigree explains why LINC looks and sounds this polished. It is also the honest caveat: world-class marketing is exactly the thing that can make an unproven health product feel proven.

The idea is genuinely sharp

Health tech has become brilliant at measuring and poor at acting, O'Connor says, and he wants LINC to be the execution layer that closes the gap between what a wearable sees and what you actually put in your body. The details are thoughtful: up to five profiles per machine, a no-wearable Custom mode, and dosing the company says adapts across the menstrual cycle rather than running the same formula every day. If people are going to take supplements anyway, making that routine easier and less wasteful is a real benefit.

But the pilot has to answer the harder question

A working machine and an in-home pilot answer the convenience question, not the one that matters. A 50-person pilot shaped by participant feedback will tell LINC whether people enjoy using it and keep using it. It will not tell anyone whether the drink improves a single health outcome, and it is not built to. The evidence that would count, that a wearable-tuned blend beats a cheap generic multivitamin, or more likely beats simply eating well, still does not exist for this category, and LINC has not produced it yet. The company says its formulations will undergo independent third-party testing. Good. That is the number I want, not the waitlist.

The takeaway

So I am rooting for LINC to do the harder thing. Automate adherence, by all means. But use these 50 homes to start answering the real question: measured markers before and after, published, with those third-party tests delivered rather than promised. LINC is still pre-launch and still untested outside its own lab, and that is not a knock, it is just the stage it is at. The difference between a clever gadget and a real health product is evidence, and the pilot is exactly where LINC could start to earn it. I hope it does.

Disclosure: the author has been in contact with LINC while researching this piece. It is unpaid, independent commentary, and LINC had no say over its content.